相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Release and uptake mechanisms of vesicular Ca2+ stores
Junsheng Yang et al.
PROTEIN & CELL (2019)
Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism
Ken-ichi Inoue et al.
MOVEMENT DISORDERS (2019)
How is alpha-synuclein cleared from the cell?
Leonidas Stefanis et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Mechanistic insights into the SNARE complex disassembly
Xuan Huang et al.
SCIENCE ADVANCES (2019)
Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Cristine Betzer et al.
EMBO REPORTS (2018)
Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress
Jaime N. Guzman et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Extracellular α-synuclein levels are regulated by neuronal activity
Kaoru Yamada et al.
MOLECULAR NEURODEGENERATION (2018)
Internalization, axonal transport and release of fibrillar forms of alpha-synuclein
Gregor Bieri et al.
NEUROBIOLOGY OF DISEASE (2018)
C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction
Janin Lautenschlager et al.
NATURE COMMUNICATIONS (2018)
Molecular Role of Ca2+ and Hard Divalent Metal Cations on Accelerated Fibrillation and Interfibrillar Aggregation of alpha-Synuclein
Jong Yoon Han et al.
SCIENTIFIC REPORTS (2018)
T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease
Yoshikuni Tabata et al.
STEM CELL REPORTS (2018)
Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease
Nadine J. Ortner et al.
JOURNAL OF NEUROSCIENCE (2017)
The Synucleinopathies: Twenty Years On
Michel Goedert et al.
JOURNAL OF PARKINSONS DISEASE (2017)
A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)
Kevin M. Biglan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin
Ori J. Lieberman et al.
ENEURO (2017)
Targeting voltage-gated calcium channels in neurological and psychiatric diseases
Gerald W. Zamponi
NATURE REVIEWS DRUG DISCOVERY (2016)
GABA transmission via ATP-dependent K+ channels regulates α-synuclein secretion in mouse striatum
Evangelia Emmanouilidou et al.
BRAIN (2016)
Ca2+ is a key factor in α-synuclein-induced neurotoxicity
Plamena R. Angelova et al.
JOURNAL OF CELL SCIENCE (2016)
Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model
Alexandre N. Rcom-H'cheo-Gauthier et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
Synaptic failure and α-synuclein
Laura Calo et al.
MOVEMENT DISORDERS (2016)
Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice
Meike Diepenbroek et al.
HUMAN MOLECULAR GENETICS (2014)
Exogenous α-Synuclein Decreases Raft Partitioning of Cav2.2 Channels Inducing Dopamine Release
Giuseppe Ronzitti et al.
JOURNAL OF NEUROSCIENCE (2014)
The T-type calcium channel as a new therapeutic target for Parkinson's disease
Ya-Chin Yang et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
T-type calcium channel blockers as neuroprotective agents
Benjamin J. Kopecky et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins
Michael J. Hurley et al.
BRAIN (2013)
The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
Mauro Cataldi
CURRENT NEUROPHARMACOLOGY (2013)
Deregulation of calcium homeostasis mediates secreted α-synuclein-induced neurotoxicity
Katerina Melachroinou et al.
NEUROBIOLOGY OF AGING (2013)
Potassium Depolarization and Raised Calcium Induces α-Synuclein Aggregates
Jordan Follett et al.
NEUROTOXICITY RESEARCH (2013)
The genetics and neuropathology of Parkinson's disease
Henry Houlden et al.
ACTA NEUROPATHOLOGICA (2012)
Use of Calcium Channel Blockers and Parkinson's Disease
Bjorn Pasternak et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
Joshua A. Goldberg et al.
NATURE NEUROSCIENCE (2012)
Physiological Phenotype and Vulnerability in Parkinson's Disease
D. James Surmeier et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Modulation of subthalamic T-type Ca2+ channels remedies locomotor deficits in a rat model of Parkinson disease
Chun-Hwei Tai et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Raised calcium promotes α-synuclein aggregate formation
S. Nath et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
E. Ilijic et al.
NEUROBIOLOGY OF DISEASE (2011)
L-Type Calcium Channel Blockers and Parkinson Disease in Denmark
Beate Ritz et al.
ANNALS OF NEUROLOGY (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Jaime N. Guzman et al.
NATURE (2010)
Endogenous Calcium Buffering Capacity of Substantia Nigral Dopamine Neurons
R. C. Foehring et al.
JOURNAL OF NEUROPHYSIOLOGY (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
A critical reappraisal of current staging of Lewy-related pathology in human brain
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2008)
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
C. Savio Chan et al.
NATURE (2007)
Parkinson's disease-associated α-synuclein is a calmodulin substrate
J Martinez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Influence of R-type (Ca(v)2.3) and T-type (Ca(v)3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis
F Bergquist et al.
NEUROSCIENCE (2003)
α-Synuclein exhibits competitive interaction between calmodulin and synthetic membranes
D Lee et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Neuronal Cav1.3α1 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines
WF Xu et al.
JOURNAL OF NEUROSCIENCE (2001)
Ca2+ binding to α-synuclein regulates ligand binding and oligomerization
MS Nielsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
